Cite
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
MLA
Serruys, Patrick W., et al. “Comparison of an Everolimus-Eluting Bioresorbable Scaffold with an Everolimus-Eluting Metallic Stent for the Treatment of Coronary Artery Stenosis (ABSORB II): A 3 Year, Randomised, Controlled, Single-Blind, Multicentre Clinical Trial.” Lancet, vol. 388, no. 10059, Nov. 2016, pp. 2479–91. EBSCOhost, https://doi.org/10.1016/S0140-6736(16)32050-5.
APA
Serruys, P. W., Chevalier, B., Yohei Sotomi, Cequier, A., Carrié, D., Piek, J. J., Van Boven, A. J., Dominici, M., Dudek, D., McClean, D., Helqvist, S., Haude, M., Reith, S., de Sousa Almeida, M., Campo, G., Iñiguez, A., Sabaté, M., Windecker, S., Yoshinobu Onuma, & Sotomi, Y. (2016). Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet, 388(10059), 2479–2491. https://doi.org/10.1016/S0140-6736(16)32050-5
Chicago
Serruys, Patrick W., Bernard Chevalier, Yohei Sotomi, Angel Cequier, Didier Carrié, Jan J. Piek, Ad J. Van Boven, et al. 2016. “Comparison of an Everolimus-Eluting Bioresorbable Scaffold with an Everolimus-Eluting Metallic Stent for the Treatment of Coronary Artery Stenosis (ABSORB II): A 3 Year, Randomised, Controlled, Single-Blind, Multicentre Clinical Trial.” Lancet 388 (10059): 2479–91. doi:10.1016/S0140-6736(16)32050-5.